Modification of Occupational Exposures on Bladder Cancer Risk by Common Genetic Polymorphisms.

Few studies have demonstrated gene/environment interactions in cancer research. Using data on high-risk occupations for 2258 case patients and 2410 control patients from two bladder cancer studies, we observed that three of 16 known or candidate bladder cancer susceptibility variants displayed statistically significant and consistent evidence of additive interactions; specifically, the GSTM1 deletion polymorphism (P interaction ≤ .001), rs11892031 (UGT1A, P interaction = .01), and rs798766 (TMEM129-TACC3-FGFR3, P interaction = .03). There was limited evidence for multiplicative interactions. When we examined detailed data on a prevalent occupational exposure associated with increased bladder cancer risk, straight metalworking fluids, we also observed statistically significant additive interaction for rs798766 (TMEM129-TACC3-FGFR3, P interaction = .02), with the interaction more apparent in patients with tumors positive for FGFR3 expression. All statistical tests were two-sided. The interaction we observed for rs798766 (TMEM129-TACC3-FGFR3) with specific exposure to straight metalworking fluids illustrates the value of integrating germline genetic variation, environmental exposures, and tumor marker data to provide insight into the mechanisms of bladder carcinogenesis.

[1]  D. Silverman,et al.  A case-control study of occupational exposure to metalworking fluids and bladder cancer risk among men , 2014, Occupational and Environmental Medicine.

[2]  William Wheeler,et al.  Genome-wide association study identifies multiple loci associated with bladder cancer risk. , 2014, Human molecular genetics.

[3]  Nilanjan Chatterjee,et al.  Common genetic polymorphisms modify the effect of smoking on absolute risk of bladder cancer. , 2013, Cancer research.

[4]  Nilanjan Chatterjee,et al.  Likelihood ratio test for detecting gene (G)-environment (E) interactions under an additive risk model exploiting G-E independence for case-control data. , 2012, American journal of epidemiology.

[5]  M. Thun,et al.  Mapping of the UGT1A locus identifies an uncommon coding variant that affects mRNA expression and protects from bladder cancer. , 2012, Human molecular genetics.

[6]  Paolo Vineis,et al.  European genome-wide association study identifies SLC14A1 as a new urinary bladder cancer susceptibility gene. , 2011, Human molecular genetics.

[7]  Jian Gu,et al.  A genome-wide association study of bladder cancer identifies a new susceptibility locus within SLC14A1, a urea transporter gene on chromosome 18q12.3. , 2011, Human molecular genetics.

[8]  Adriano Decarli,et al.  Risk factor modification and projections of absolute breast cancer risk. , 2011, Journal of the National Cancer Institute.

[9]  N. Malats,et al.  A single nucleotide polymorphism tags variation in the arylamine N-acetyltransferase 2 phenotype in populations of European background , 2010, Pharmacogenetics and genomics.

[10]  Margaret R Karagas,et al.  Occupation and bladder cancer in a population-based case–control study in Northern New England , 2010, Occupational and Environmental Medicine.

[11]  William Wheeler,et al.  A multi-stage genome-wide association study of bladder cancer identifies multiple susceptibility loci , 2010, Nature Genetics.

[12]  Paolo Vineis,et al.  A sequence variant at 4p16.3 confers susceptibility to urinary bladder cancer , 2010, Nature Genetics.

[13]  D. Silverman,et al.  A case-control study of smoking and bladder cancer risk: emergent patterns over time. , 2009, Journal of the National Cancer Institute.

[14]  Jan G. Hengstler,et al.  Susceptibility to urinary bladder cancer: relevance of rs9642880[T], GSTM1 0/0 and occupational exposure. , 2009, Pharmacogenetics and genomics.

[15]  Jian Gu,et al.  Genetic variation in the prostate stem cell antigen gene PSCA confers susceptibility to urinary bladder cancer , 2009, Nature Genetics.

[16]  Paolo Vineis,et al.  Sequence variants at the TERT-CLPTM1L locus associate with many cancer types , 2009, Nature Genetics.

[17]  Tony Fletcher,et al.  Sequence variant on 8q24 confers susceptibility to urinary bladder cancer , 2008, Nature Genetics.

[18]  N. Malats,et al.  Occupation and bladder cancer in a hospital-based case–control study in Spain , 2007, Occupational and Environmental Medicine.

[19]  A. Zlotta NAT2 Slow Acetylation, GSTM1 Null Genotype, and Risk of Bladder Cancer: Results from the Spanish Bladder Cancer Study and Meta-Analyses , 2006 .

[20]  Henry J. Lin,et al.  Pooled analysis and meta-analysis of glutathione S-transferase M1 and bladder cancer: a HuGE review. , 2002, American journal of epidemiology.

[21]  H. Ozen Bladder cancer. , 1998, Current opinion in oncology.

[22]  Schulze,et al.  N-Acetyltransferase 2 (NAT2) and Glutathione S-Transferase µ (GSTM1) in Bladder-cancer Patients in a Highly Industrialized Area. , 1997, International journal of occupational and environmental health.